Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,523 | -620 | -25,113 | -1,907 | -653 |
| Depreciation Amortization | 513 | 317 | 2,320 | 1,006 | 978 |
| Income taxes - deferred | N/A | N/A | 1,333 | -580 | -648 |
| Accounts receivable | 1,498 | 1,191 | 5,448 | -4,697 | -2,883 |
| Other Working Capital | 1,078 | 675 | 5,348 | -43 | -1,011 |
| Other Operating Activity | 4,788 | -1,219 | 16,540 | 6,015 | 4,655 |
| Operating Cash Flow | $354 | $343 | $5,877 | $-207 | $440 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -60 | -31 | -31 |
| Other Investing Activity | 0 | 0 | -7,318 | -1,623 | -1,636 |
| Investing Cash Flow | $N/A | $N/A | $-7,378 | $-1,654 | $-1,667 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -283 | -283 | -161 | -187 | -188 |
| Financing Cash Flow | $-283 | $-283 | $-161 | $-187 | $-188 |
| Exchange Rate Effect | 98 | -8 | 15 | 474 | 43 |
| Beginning Cash Position | 39 | 39 | 1,685 | 1,685 | 1,685 |
| End Cash Position | 207 | 92 | 39 | 112 | 313 |
| Net Cash Flow | $168 | $53 | $-1,646 | $-1,573 | $-1,372 |
| Free Cash Flow | |||||
| Operating Cash Flow | 354 | 343 | 5,877 | -207 | 440 |
| Capital Expenditure | N/A | N/A | -60 | -31 | -31 |
| Free Cash Flow | 354 | 343 | 5,818 | -237 | 409 |